6 Orthobiologic Companies Move Clinical Trials Forward
Multiple orthobiologic companies have engaged in clinical trials in 2019, seeking to demonstrate the efficacy of their cell-based products. We've...
Dec 12 2019,
Competitive Landscape
10 Takeaways from Orthopedics in 2019
Acquisitions, biologics, enabling technology and loss of market share by the big players all made our list. Read the specifics and...
Dec 12 2019,
Smith+Nephew Announces First JOURNEY II Unicompartmental Knee Procedures
The JOURNEY II Uni Knee is designed to bring the natural feel of JOURNEY II to partial knee arthroplasty patients...
Dec 10 2019,
Empirical Spine Completes Portion of Enrollment for LimiFlex Clinical Trial
Enrollment is complete in the investigational arm of the U.S. IDE trial of the LimiFlex Paraspinous Tension Band with decompression....
Dec 10 2019,
ulrich medical USA Launches Momentum Posterior Spinal Fixation
Momentum is compatible with the company's neon3 Universal OCT Spinal Stabilization System, which launched in 2012....
Dec 10 2019,
Executive Interview: Carmell Therapeutics on its Controlled Degradable Biologic
Carmell Therapeutics' proprietary process binds and cross-links regenerative factors in lyophilized platelet-enriched plasma into solid and semi-solid plasma-based materials to...
Dec 10 2019,
Strategic Initiatives: CrossRoads Extremity Builds Portfolio, Mathys and BREHM to Co-Market Products
A growing extremities company grows even more, and two well-established joint replacement players collaborate globally on components for hip replacement....
Dec 03 2019,
4 New Technologies in Spine, Joint Replacement, Trauma, Sports Medicine
Small and mid-sized orthopedic companies bolstered their portfolios at year-end with products to help grow revenue in the coming year....
Dec 03 2019,
New Venture Capital Firm Vensana has Orthopedic Roots
Vensana Capital announced a $225 million fund to build a portfolio of 10 to 12 companies. The firm's founders have...
Dec 02 2019,
Lack of Clinical Evidence Leaves Questions about Orthobiologic Development and Promotion
In the race to capitalize on patient-driven interest in stem cells, biologic and regenerative solutions, there has been an explosion...
Dec 02 2019,
CMS to Remove Total Hip Replacement, Certain Spine Procedures from Inpatient Only List
Removal of these procedures from the inpatient-only list makes them eligible to be paid by Medicare in hospital outpatient and...
Dec 02 2019,
3 FDA Actions to Reduce Ethylene Oxide Sterilization
FDA has prioritized the reduction of ethylene oxide to sterilize medical devices. Recent announcements from the agency provide orthopedic manufacturers insight...
Dec 02 2019,
Globus Medical Leaders Discuss Joint Replacement and Robotics Expansion
We sat down with leaders from Globus Medical to discuss their entrance into the joint replacement market, robotics’ role in...
Dec 02 2019,
Knee and Spine Osteoarthritis Ripe Areas for New Orthobiologic Products
Dr. Steven Sampson, Founder of the well-known TOBI Symposium, shares his take on the state of regenerative medicine and the...
Dec 02 2019,
Orthopedic OEMs Seek to Outsource More Design Work
Suppliers and design firms are expanding their capabilities in anticipation of orthopedic device manufacturers outsourcing more product development work. We...
Dec 02 2019,